A Novel Engineered IL-21 Receptor Arms T-Cell Receptor-Engineered T Cells (TCR-T Cells) Against Hepatocellular Carcinoma

Researchers determined the combination effects of IL-21 in T cell therapy against HCC and investigate optimized strategies to utilize the effect of IL-21 signal in T cell therapy.